Medgenics to Present at the Rodman & Renshaw 18th Annual Global Investment Conference
September 06, 2016 08:00 ET
|
Medgenics, Inc.
PHILADELPHIA, PA--(Marketwired - Sep 6, 2016) - Medgenics, Inc. (NYSE MKT: MDGN) today announced that Michael F. Cola, President and Chief Executive Officer, will present at the Rodman & Renshaw...
Medgenics Reports Second Quarter 2016 Financial Results
August 04, 2016 08:00 ET
|
Medgenics, Inc.
PHILADELPHIA, PA--(Marketwired - Aug 4, 2016) - Medgenics, Inc. (NYSE MKT: MDGN)
Initiated Phase 2/3 study of lead program in mGluR+ ADHD
Entered...
Medgenics to Host Conference Call to Announce Second Quarter 2016 Financial Results
July 27, 2016 12:00 ET
|
Medgenics, Inc.
PHILADELPHIA, PA--(Marketwired - Jul 27, 2016) - Medgenics, Inc. (NYSE MKT: MDGN) will host a conference call and live audio webcast on Thursday, August 4, 2016 at 8:30 a.m. EDT to report financial...
Medgenics Announces Pricing of Public Offering of Common Stock
June 21, 2016 09:00 ET
|
Medgenics, Inc.
PHILADELPHIA, PA--(Marketwired - Jun 21, 2016) - Medgenics, Inc. (NYSE MKT: MDGN) today announced the pricing of 3,640,000 shares of its common stock in a previously announced underwritten...
Medgenics Announces Public Offering of Common Stock
June 20, 2016 16:00 ET
|
Medgenics, Inc.
PHILADELPHIA, PA--(Marketwired - Jun 20, 2016) - Medgenics, Inc. (NYSE: MDGN), a clinical-stage biopharmaceutical company, today announced its intention to offer and sell shares of its common stock...
Medgenics Announces Enrollment of First Patient in Phase 2/3 Clinical Trial of NFC-1 in Adolescents With mGluR Mutation Positive ADHD
June 17, 2016 08:00 ET
|
Medgenics, Inc.
PHILADELPHIA, PA--(Marketwired - Jun 17, 2016) - Medgenics, Inc. (NYSE: MDGN) today announced the enrollment of the first patient into the SAGA (Study of Adolescent Glutamate Receptor Network Copy...
Medgenics to Present at the JMP Life Sciences Conference
June 15, 2016 08:00 ET
|
Medgenics, Inc.
PHILADELPHIA, PA--(Marketwired - Jun 15, 2016) - Medgenics, Inc. (NYSE MKT: MDGN) today announced that Michael F. Cola, President and Chief Executive Officer, will present at the JMP Life Sciences...
Medgenics Obtains Rights to First-in-Class Biologic for Severe Pediatric Onset IBD
June 06, 2016 07:00 ET
|
Medgenics, Inc.
PHILADELPHIA, PA--(Marketwired - Jun 6, 2016) - (NYSE MKT: MDGN)
Collaboration with Kyowa Hakko Kirin to develop anti-LIGHT monoclonal antibody
Second...
Medgenics to Present at the Jefferies 2016 Global Healthcare Conference
June 01, 2016 08:30 ET
|
Medgenics, Inc.
PHILADELPHIA, PA--(Marketwired - Jun 1, 2016) - Medgenics, Inc. (NYSE MKT: MDGN) today announced that Michael F. Cola, President and Chief Executive Officer, will present at the Jefferies 2016...
Medgenics to Present at the UBS Global Healthcare Conference
May 20, 2016 08:00 ET
|
Medgenics, Inc.
PHILADELPHIA, PA--(Marketwired - May 20, 2016) - Medgenics, Inc. (NYSE MKT: MDGN) today announced that Michael F. Cola, President and Chief Executive Officer, will present at the annual UBS Global...